甲磺酸萘莫司他（Nafamostat ...

Eribulin exerts its pharmacologic effects by binding to the plus ends of microtubules and suppressing microtubule growth, without affecting microtubule shortening, and by inducing the formation of ...

The FDA has accepted a supplemental new drug application (sNDA) seeking expanded indication for darolutamide (Nubeqa) for use in combination with androgen deprivation therapy (ADT) for the treatment ...

分子量：400、600、1k、2k、3.4k、5k、10k、20k等，可根据具体需求进行定制。 溶解性：该化合物具有良好的水溶性，能够稳定地存在于水溶液中。 结构式： 化学结构：Hydroxyl-PEG-OMS由PEG链段和甲磺酸酯基团组成，PEG链段上的羟基与甲磺酸酯基团通过化学键相连 ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

The pharmaceutical company behind mesylate submitted a new drug application for a ready-to-use 3-month formulation of the drug. Foresee Pharmaceuticals submitted to the FDA a 502(b)(2) new drug ...